Aqr Capital Management LLC Praxis Precision Medicines, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $4.98 $68,748 - $427,956	-85,935 Reduced 53.53%	74,594 $60,000
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $171,499 - $3.33 Million	-91,223 Reduced 36.24%	160,529 $382,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $585,890 - $8.89 Million	234,356 Added 1347.18%	251,752 $571,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $30,443 - $197,270	17,396 New	17,396 $43,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.